Zimmer Biomet Holdings, Inc. Forecast, price target & analysts
Zimmer Biomet Holdings, Inc. Target price 2025 - Analyst rating & recommendation
Zimmer Biomet Holdings, Inc. Classifications & Recommendation:
Zimmer Biomet Holdings, Inc. Price Target
| Target Price | $120.00 |
| Price | $104.05 |
| Potential |
15.33%
register free of charge
|
| Number of Estimates | 25 |
|
25 Analysts have issued a price target Zimmer Biomet Holdings, Inc. 2026 .
The average Zimmer Biomet Holdings, Inc. target price is $120.00.
This is
15.33%
register free of charge
$140.00
34.55%
register free of charge
$105.00
0.91%
register free of charge
|
|
| A rating was issued by 31 analysts: 12 Analysts recommend Zimmer Biomet Holdings, Inc. to buy, 17 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Zimmer Biomet Holdings, Inc. stock has an average upside potential 2026 of
15.33%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 7.68 | 7.88 |
| 3.85% | 2.66% | |
| EBITDA Margin | 30.80% | 34.48% |
| 2.61% | 11.93% | |
| Net Margin | 11.49% | 12.12% |
| 12.58% | 5.51% |
26 Analysts have issued a sales forecast Zimmer Biomet Holdings, Inc. 2025 . The average Zimmer Biomet Holdings, Inc. sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Zimmer Biomet Holdings, Inc. EBITDA forecast 2025. The average Zimmer Biomet Holdings, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Zimmer Biomet Holdings, Inc. Analysts have issued a net profit forecast 2025. The average Zimmer Biomet Holdings, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 4.43 | 4.80 |
| 9.22% | 8.35% | |
| P/E | 21.69 | |
| EV/Sales | 3.37 |
10 Analysts have issued a Zimmer Biomet Holdings, Inc. forecast for earnings per share. The average Zimmer Biomet Holdings, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Zimmer Biomet Holdings, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Zimmer Biomet Holdings, Inc....
Current Zimmer Biomet Holdings, Inc. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays | Locked ➜ Locked | Locked | Feb 10 2025 |
| Truist Securities | Locked ➜ Locked | Locked | Feb 10 2025 |
| Raymond James | Locked ➜ Locked | Locked | Feb 07 2025 |
| RBC Capital | Locked ➜ Locked | Locked | Feb 07 2025 |
| Needham | Locked ➜ Locked | Locked | Feb 07 2025 |
| JMP Securities | Locked ➜ Locked | Locked | Feb 07 2025 |
| Needham | Locked ➜ Locked | Locked | Jan 29 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Barclays: Locked ➜ Locked
|
Feb 10 2025 |
|
Locked
Truist Securities: Locked ➜ Locked
|
Feb 10 2025 |
|
Locked
Raymond James: Locked ➜ Locked
|
Feb 07 2025 |
|
Locked
RBC Capital: Locked ➜ Locked
|
Feb 07 2025 |
|
Locked
Needham: Locked ➜ Locked
|
Feb 07 2025 |
|
Locked
JMP Securities: Locked ➜ Locked
|
Feb 07 2025 |
|
Locked
Needham: Locked ➜ Locked
|
Jan 29 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
